0.99% 0.0011

Biofrontera Inc (BFRI)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Biofrontera Inc Stock (BFRI) Company Profile

Biofrontera Inc

Healthcare (1155)

781-245-1325

120 PRESIDENTIAL WAY,, WOBURN

Prossima data di guadagno

Ultimi documenti SEC

BFRI's Discussions on Twitter

Confronta BFRI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BFRI Biofrontera Inc	0.8111	7.60M	34.07M	-20.13M	-24.90M	-12.92
ZTS Zoetis Inc	150.07	66.56B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.47	45.61B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	15.32	45.01B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	13.97	15.25B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	293.09	12.79B	2.76B	1.11B	898.10M	22.77

Biofrontera Inc Borsa (BFRI) Ultime notizie

Biofrontera Inc Azioni (BFRI) Dati Finanziari

Biofrontera Inc (BFRI)

Biofrontera Inc Stock (BFRI) Company Profile

Confronta BFRI con altri titoli

Biofrontera Inc Borsa (BFRI) Ultime notizie

Biofrontera Inc. (NASDAQ:BFRI) Sees Large Decrease in Short Interest - Defense World

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - Revista ADVFN

Biofrontera Inc. Reports Record Sales and Strategic Advances - MSN

Virtu Financial LLC Invests $48,000 in Biofrontera Inc. (NASDAQ:BFRI) - The AM Reporter

Benchmark maintains Buy rating on Biofrontera stock, target at $7 By Investing.com - Investing.com Australia

Biofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Call Transcript - MSN

Benchmark maintains Buy rating on Biofrontera stock, target at $7 - Investing.com India

Biofrontera outlines 2025 growth strategies with new FDA approvals and clinical progress - MSN

Biofrontera Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada

Biofrontera Inc. Q4 2024 Earnings: A Deep Dive into the Numbers - AInvest

Biofrontera Inc. Reports Record Revenue Growth in 2024 - TipRanks

Biofrontera Inc. reports Q4 EPS (19c) vs $1.65 last year - TipRanks

Earnings call transcript: Biofrontera Q4 2024 sees revenue growth and strategic shifts - Investing.com India

Biofrontera Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - TradingView

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - GlobeNewswire Inc.

Earnings Scheduled For March 21, 2025 - Benzinga

Biofrontera Inc. (BFRI) reports earnings - Quartz

Biofrontera Inc. SEC 10-K Report - TradingView

Biofrontera Completes Patient Enrollment for Phase 3 Trial of Ameluz in Actinic Keratoses - Marketscreener.com

Biofrontera completes patient enrollment in Phase 3 study of Ameluz - TipRanks

Biofrontera Inc. Announces Completion of Patient Enrollment - GlobeNewswire

Major Milestone: Biofrontera's Skin Cancer Treatment Targets New Body Areas in Phase 3 Trial - StockTitan

3 Reasons to Avoid KIND and 1 Stock to Buy Instead - The Globe and Mail

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk - GlobeNewswire

Biofrontera (BFRI) to Release Earnings on Friday - Defense World

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - GlobeNewswire

BIOFRONTERA Earnings Preview: Recent $BFRI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Dermatology Leader Biofrontera Sets Q4 Earnings Date: Key Growth Updates Expected - StockTitan

Biofrontera (BFRI) Projected to Post Earnings on Thursday - Defense World

Biofrontera Inc. (NASDAQ:BFRI) Short Interest Down 25.0% in February - Defense World

Investors Aren't Entirely Convinced By Biofrontera Inc.'s (NASDAQ:BFRI) Revenues - Simply Wall St

When Will Biofrontera Inc. (NASDAQ:BFRI) Turn A Profit? - Yahoo Finance

Biofrontera (NASDAQ:BFRI) Trading Down 3.5% – What’s Next? - Defense World

Constellation Brands: A Fallen Star or a Hidden Value Play? - The Globe and Mail

Head-To-Head Contrast: Indaptus Therapeutics (NASDAQ:INDP) vs. Biofrontera (NASDAQ:BFRI) - Defense World

Biofrontera (NASDAQ:BFRI) vs. Sage Therapeutics (NASDAQ:SAGE) Critical Contrast - Defense World

Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts - ACCESS Newswire

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals - ACCESS Newswire

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 - ACCESS Newswire

Bibi go up tomorrow - AInvest

Biofrontera Inc. Announces Preliminary Third Quarter Revenues - ACCESS Newswire

Biofrontera says last patient completed one-year follow-up in Ameluz-PDT study - TipRanks

Biofrontera Inc. Announces Achievement of Key Milestone In - GlobeNewswire

Biofrontera's Ameluz-PDT Skin Cancer Treatment Hits All Phase 3 Endpoints with Strong Results - StockTitan

Photonics IP Update: December 2024 - Laser Focus World

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market - The Manila Times

Biofrontera Hits Major Milestone: 100th RhodoLED® XL Lamp Installed as PDT Treatment Demand Surges - StockTitan

Opendoor Technologies Inc (OPEN-Q) QuotePress Release - The Globe and Mail

Financial Contrast: Biofrontera (NASDAQ:BFRI) versus Amicus Therapeutics (NASDAQ:FOLD) - Defense World

Biofrontera Inc Azioni (BFRI) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a BFRI